Hosted on MSN2mon
Breakthrough in Vision: Ocugen’s OCU400 Shows Promising 2-Year Results for Retinitis PigmentosaNotably, treated eyes achieved a statistically significant two-line gain (10 letters) in low-luminance visual acuity (LLVA) on the ETDRS chart, regardless of genetic mutation, with a p-value of 0.01.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback